Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07526571) titled 'GLOW Study: Effects of Triple Protein in Women' on April 6.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Double (Participant, Investigator).
Primary Sponsor: University of North Carolina, Chapel Hill
Condition:
Healthy Women
Intervention:
Dietary Supplement: Triple protein support
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: April 2026
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07526571
Published by HT Di...